ArticleFrontiers in endocrinology2025

Risk factors for denosumab-related osteonecrosis of the jaw: a pharmacovigilance study using the U.S. FDA adverse event reporting system database.

Hehe Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.